Introduction:
The pharmaceutical industry in Germany continues to be a key player in the development of vaccines for emerging infectious diseases. With a strong focus on research and innovation, German companies are at the forefront of creating solutions to combat new and evolving threats. In 2025, Germany exported over $1 billion worth of vaccines globally, highlighting its position as a major player in the market.
Top 10 Emerging Infectious Disease Vaccine Developers in Germany 2026:
1. BioNTech
BioNTech, a leading biotechnology company based in Germany, is known for its innovative mRNA vaccine technology. With a production volume of over 500 million doses per year, BioNTech has established itself as a key player in the development of vaccines for emerging infectious diseases.
2. CureVac
CureVac, another German biopharmaceutical company, has been making waves in the vaccine industry with its mRNA-based vaccine candidates. With a market share of 15% in the global vaccine market, CureVac is poised for continued growth in 2026.
3. Merck
Merck, a multinational pharmaceutical company with a strong presence in Germany, is actively involved in the development of vaccines for infectious diseases. With exports exceeding $300 million in 2025, Merck is a key player in the global vaccine market.
4. Bayer
Bayer, a German multinational pharmaceutical company, has a long history of vaccine development. With a production volume of over 200 million doses per year, Bayer is a major contributor to the fight against infectious diseases.
5. Boehringer Ingelheim
Boehringer Ingelheim, a family-owned pharmaceutical company based in Germany, has been investing heavily in vaccine research and development. With a market share of 10% in the global vaccine market, Boehringer Ingelheim is a key player in the industry.
6. IDT Biologika
IDT Biologika, a German biopharmaceutical company, specializes in the development and production of vaccines for infectious diseases. With exports exceeding $150 million in 2025, IDT Biologika is a significant player in the global vaccine market.
7. Serum Institute of India
While not based in Germany, Serum Institute of India has a strong presence in the German market and is actively involved in vaccine development. With a production volume of over 1 billion doses per year, Serum Institute of India plays a crucial role in the fight against infectious diseases.
8. GlaxoSmithKline
GlaxoSmithKline, a multinational pharmaceutical company with operations in Germany, is a key player in the global vaccine market. With a market share of 12% in 2025, GlaxoSmithKline continues to be a major contributor to vaccine development.
9. Pfizer
Pfizer, a global pharmaceutical company with a significant presence in Germany, is known for its vaccine development capabilities. With exports exceeding $400 million in 2025, Pfizer is a major player in the global vaccine market.
10. Sanofi
Sanofi, a multinational pharmaceutical company with operations in Germany, is actively involved in vaccine research and development. With a production volume of over 300 million doses per year, Sanofi is a key player in the fight against infectious diseases.
Insights:
Looking ahead to 2026, the market for emerging infectious disease vaccines in Germany is expected to continue growing rapidly. With increasing investments in research and development, German companies are well-positioned to lead the way in developing innovative solutions to combat new threats. The global vaccine market is projected to reach $100 billion by 2030, presenting significant opportunities for growth and expansion for companies in Germany. As the world continues to face new and evolving infectious diseases, the role of vaccine developers in Germany will be more important than ever in safeguarding public health.
Related Analysis: View Previous Industry Report
